Upcoming Global Web Symposia
October 31, 2012
12:00 p.m. - 1:30 p.m. EDT
Receptor Antagonism Trailer
Two types of receptor antagonist mechanism will be discussed: steric hindrance and allosteric modulation. Methods to quantify the affinity of orthosteric antagonists producing competitive and non-competitive antagonism will be described and the emerging therapeutic importance of allosteric modulation will be highlighted. Methods to detect allosteric and quantify allosteric effects from antagonism to potentiation of agonist response will be discussed. The importance of receptor offset rates will be considered in terms of therapeutic target coverage along with methods to measure antagonist kinetics of offset.
Terry Kenakin Ph.D., Director in Biological Reagents & Assay Development, GlaxoSmithKline Research and Development
Who Should Attend
Instructor Information: Terry Kenakin Ph.D.
Professor, Department of Pharmacology
University of North Carolina School of Medicine
Chapel Hill NC
Instructor Biography:Terrence Kenakin, Ph.D., is Professor in the Department of Pharmacology, University of North Carolina, Chapel Hill. Until August of 2011, Dr. Kenakin was director of research at GlaxoSmithKline Research and Development laboratories at Research Triangle Park, NC where he optimized drug activity assay systems for the discovery and testing of. allosteric molecules mostly for the treatment of diabetes. Before starting the major stint of his drug discovery career at GSK, Dr. Kenakin was an associate scientist at Burroughs-Wellcome in the U.K. which he joined after a post-doctoral fellowship at University College London, U.K. Dr. Kenakin earned his Ph.D. in Pharmacology at the University of Alberta, Edmonton Canada.
Dr. Kenakin is a member of many editorial boards as well as Co-editor-in-Chief of the Journal of Receptors and Signal Transduction. In addition, he has authored numerous articles and has written eight books on pharmacology, including the popular "A Pharmacology Primer".
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: email@example.com
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesreportsbarnett educational servicesconsultingpublications & eNewslettersKnowledge Foundation professional services
executive teamtestimonialschi timelinemailing listcareers